|
|
||||||||
RAPID COMMUNICATION |
a The Walther Oncology Center,
b Department of Pediatrics and Wells Center for Pediatric Research, James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis, Indiana;
c Department of Anesthesia, Kyoto University Hospital, and the Institute for Virus Research, Kyoto University, Kyoto, Japan;
d The Center for Animal Transgenesis and Germ Cell Research, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania;
e Department of Internal Medicine, and the Cancer Treatment and Research Center, the University of New Mexico, Albuquerque, New Mexico
Key Words. Embryonic stem cells • Transcription factors • Differentiation • Oxidation
Robert Hromas, M.D., Department of Internal Medicine, and the Cancer Treatment and Research Center, University of New Mexico, 900 Camino de Salud, Albuquerque, New Mexico 87131, USA. Telephone: 505-272-5837; Fax: 505-272-5865; email: rhromas{at}salud.unm.edu
Oct-4 is a transcriptional regulator required to maintain the totipotentiality of embryonic stem (ES) cells. Downregulation of its activity is required for proper differentiation of the blastocyst during uterine implantation. Uterine implantation and subsequent vascularization increase oxygen exposure of the developing embryo, thereby altering the intracellular reduction-oxidation status. We tested whether Oct-4 could be regulated by these changes in reduction-oxidation status. We found that Oct-4 DNA binding was exquisitely sensitive to abrogation by oxidation but that the DNA binding of another ES cell transcription factor, FoxD3, was much less sensitive to oxidation. The reducing enzyme Thioredoxin (but not Ape-1) could restore DNA-binding activity of Oct-4. Thioredoxin was less effective at restoring the DNA-binding ability of FoxD3. It was also found that Thioredoxin (but not Ape-1) could physically associate with cysteines in the POU domain of Oct-4. Finally, overexpressing normal Thioredoxin increased the transcriptional activity of Oct-4, while overexpressing a mutant Thioredoxin decreased the transcriptional activity of Oct-4. These data imply that ES cell transcription factors are differentially sensitive to oxidation and that Thioredoxin may differentially regulate ES cell transcription factors.
This article has been cited by other articles:
![]() |
W. A. Chutkow, P. Patwari, J. Yoshioka, and R. T. Lee Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production J. Biol. Chem., January 25, 2008; 283(4): 2397 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Range, F. Lapraz, M. Quirin, S. Marro, L. Besnardeau, and T. Lepage Cis-regulatory analysis of nodal and maternal control of dorsal-ventral axis formation by Univin, a TGF-{beta} related to Vg1 Development, October 15, 2007; 134(20): 3649 - 3664. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Patwari, L. J. Higgins, W. A. Chutkow, J. Yoshioka, and R. T. Lee The Interaction of Thioredoxin with Txnip: EVIDENCE FOR FORMATION OF A MIXED DISULFIDE BY DISULFIDE EXCHANGE J. Biol. Chem., August 4, 2006; 281(31): 21884 - 21891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M.G. Reyes, S. Fermanian, F. Yang, S.-Y. Zhou, S. Herretes, D. B. Murphy, J. H. Elisseeff, and R. S. Chuck Metabolic Changes in Mesenchymal Stem Cells in Osteogenic Medium Measured by Autofluorescence Spectroscopy Stem Cells, May 1, 2006; 24(5): 1213 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tantin, C. Schild-Poulter, V. Wang, R. J.G. Hache, and P. A. Sharp The Octamer Binding Transcription Factor Oct-1 Is a Stress Sensor Cancer Res., December 1, 2005; 65(23): 10750 - 10758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lapointe, S. Kimmins, L. A. MacLaren, and J.-F. Bilodeau Estrogen Selectively Up-Regulates the Phospholipid Hydroperoxide Glutathione Peroxidase in the Oviducts Endocrinology, June 1, 2005; 146(6): 2583 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hansen, W. H. Watson, and D. P. Jones Compartmentation of Nrf-2 Redox Control: Regulation of Cytoplasmic Activation by Glutathione and DNA Binding by Thioredoxin-1 Toxicol. Sci., November 1, 2004; 82(1): 308 - 317. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
